Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Clonal hematopoiesis in lung adenocarcinoma pathogenesis
Tiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, Yuyan Cai, Marie McConkey, Christopher J. Gibson, Benjamin L. Ebert, Peter Miller, Tyler Jacks
Tiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, Yuyan Cai, Marie McConkey, Christopher J. Gibson, Benjamin L. Ebert, Peter Miller, Tyler Jacks
View: Text | PDF
Research Letter Hematology Oncology

Clonal hematopoiesis in lung adenocarcinoma pathogenesis

  • Text
  • PDF
Abstract

Authors

Tiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, Yuyan Cai, Marie McConkey, Christopher J. Gibson, Benjamin L. Ebert, Peter Miller, Tyler Jacks

×

Figure 1

Effects of TET2-mutant CH on LUAD and immune cell repertoire.

Options: View larger image (or click on image) Download as PowerPoint
Effects of TET2-mutant CH on LUAD and immune cell repertoire.
(A) Experi...
(A) Experimental approach. (B) Flow cytometry analyses of peripheral blood. Each dot represents a mouse (n = 11–24). (C) Tumor burden and grade at 16 weeks. Each dot represents a mouse (n = 30–32). (D) Images of lymphoid aggregates (LAs) in non-tumor bearing lungs. (E) IHC of lung from Tet2 KO mouse (top) and relative quantification within LAs. Each color represents data from a single mouse (n = 4–11). (F) IHC quantification of immune cells within tumors. Each color represents data from a single mouse (n = 9–11). Data are from 2 or 3 independent experiments at 16-week time point (color-coded in B and C). Circles represent color-coded means, and data are shown as mean ± SEM. Statistical analyses were performed with 1-way ANOVA tests (B, Tukey, E, Brown-Forsythe and Welch nested), in C with the Mann-Whitney U test, and in F with 2-tailed nested t test of nested. T, tumor. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts